CompanyAKBANasdaqCambridge, MA

Akebia Therapeutics

Akebia Therapeutics develops treatments for kidney disease.

SEC EDGAR ClinicalTrials.gov ir.akebia.com

8-KSep 22Latest SEC filing, period to Sep 18

Sep 22Latest story

August 2026

Akebia reports Q2 2026 results, VOICE interim data, and new ebribafusp trial

Aug 5Quarterly updateAkebia Therapeutics vadadustat

June 2026

Akebia and USRC halt VOICE trial early after Vafseo beats ESA on safety

Jun 30Clinical readoutAkebia Therapeutics vadadustat